Radformation and Icon Group join forces to transform cancer care
BRISBANE: Radformation, a leader in radiation oncology software, and Icon Group, a global provider of cancer care, have announced a strategic partnership to improve treatment...
Jazz Pharmaceuticals acquires Redx’s KRAS inhibitor program
Alderley Park, UK: Jazz Pharmaceuticals plc and Redx Pharma plc have signed a definitive agreement under which Jazz will acquire Redx’s KRAS (Kirsten rat sarcoma...
Merck & Co. seeks to acquire Seagen in a reportedly $40 billion deal
NEW YORK: Merck & Co. seeks to acquire Seagen in a reportedly $40 billion deal or more, the Wall Street Journal reported Thursday. While talks could fall...